淋巴细胞白血病-话题@MedSci

#淋巴细胞白血病#

277篇内容 | 4737人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1997936, encodeId=21e0199e93693, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：Venetoclax联合奥比妥单抗治疗慢性淋巴细胞白血病的疗效和安全性, objectType=article, longId=162665, objectId=94c4162665d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94c4162665d4, replyNumber=0, likeNumber=104, createdTime=2020-01-09, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94c4162665d4, moduleTitle=Blood：Venetoclax联合奥比妥单抗治疗慢性淋巴细胞白血病的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94c4162665d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997927, encodeId=6e6a199e92756, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：依鲁替尼联合利妥昔单抗与依鲁替尼单药治疗慢性淋巴细胞白血病的效果对比, objectType=article, longId=155412, objectId=d77e1554121e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d77e1554121e, replyNumber=0, likeNumber=68, createdTime=2019-04-16, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d77e1554121e, moduleTitle=Blood：依鲁替尼联合利妥昔单抗与依鲁替尼单药治疗慢性淋巴细胞白血病的效果对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d77e1554121e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997929, encodeId=0c25199e929e3, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=CAR-T治疗复发难治急性B淋巴细胞白血病缓解率高, objectType=article, longId=156549, objectId=961e1565496f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=961e1565496f, replyNumber=0, likeNumber=63, createdTime=2019-06-29, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=961e1565496f, moduleTitle=CAR-T治疗复发难治急性B淋巴细胞白血病缓解率高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=961e1565496f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997942, encodeId=df63199e9425f, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NCCN临床实践指南：急性淋巴细胞白血病（2019.V1）, objectType=article, longId=165020, objectId=aa4916502082, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa4916502082, replyNumber=0, likeNumber=20, createdTime=2020-01-14, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa4916502082, moduleTitle=NCCN临床实践指南：急性淋巴细胞白血病（2019.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa4916502082)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997921, encodeId=a2dd199e92189, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=【2018 ASH】徐卫教授速递：伊布替尼在慢性淋巴细胞白血病领域治疗取得哪些突破？, objectType=article, longId=154583, objectId=9a80154583ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a80154583ac, replyNumber=0, likeNumber=23, createdTime=2019-11-04, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a80154583ac, moduleTitle=【2018 ASH】徐卫教授速递：伊布替尼在慢性淋巴细胞白血病领域治疗取得哪些突破？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a80154583ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997915, encodeId=0425199e9154f, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=儿童急性淋巴细胞白血病诊疗规范（2018版）, objectType=article, longId=151564, objectId=687a1515640e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=687a1515640e, replyNumber=0, likeNumber=19, createdTime=2019-07-04, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=687a1515640e, moduleTitle=儿童急性淋巴细胞白血病诊疗规范（2018版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=687a1515640e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997948, encodeId=27d0199e9486b, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2019 EHA：AZ的BTK抑制剂Calquence显着延长慢性淋巴细胞白血病患者的无进展生存期, objectType=article, longId=168695, objectId=da9416869531, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da9416869531, replyNumber=0, likeNumber=71, createdTime=2019-10-01, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da9416869531, moduleTitle=2019 EHA：AZ的BTK抑制剂Calquence显着延长慢性淋巴细胞白血病患者的无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da9416869531)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997924, encodeId=19cc199e924e6, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2018年ASH年会：KTE-X19治疗成人复发难治急性淋巴细胞白血病患者的全新结果, objectType=article, longId=155289, objectId=eab415528991, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eab415528991, replyNumber=0, likeNumber=60, createdTime=2019-04-04, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eab415528991, moduleTitle=2018年ASH年会：KTE-X19治疗成人复发难治急性淋巴细胞白血病患者的全新结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eab415528991)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997943, encodeId=53f2199e943ba, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=慢性淋巴细胞白血病：Calquence达到III期临床试验的主要终点, objectType=article, longId=165652, objectId=69a116565258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69a116565258, replyNumber=0, likeNumber=55, createdTime=2020-01-23, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69a116565258, moduleTitle=慢性淋巴细胞白血病：Calquence达到III期临床试验的主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69a116565258)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997912, encodeId=3239199e912ce, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=AbbVie的BCL-2抑制剂VENCLEXTA获得加拿大批准与利妥昔单抗联合治疗慢性淋巴细胞白血病患者, objectType=article, longId=149701, objectId=7340149e01c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7340149e01c4, replyNumber=0, likeNumber=59, createdTime=2019-04-24, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7340149e01c4, moduleTitle=AbbVie的BCL-2抑制剂VENCLEXTA获得加拿大批准与利妥昔单抗联合治疗慢性淋巴细胞白血病患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7340149e01c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997934, encodeId=c15c199e9348e, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=INT J LAB HEMATOL：利用CD81/CD58的表达率很容易从B细胞祖细胞急性淋巴细胞白血病患者淋巴母细胞中识别造血细胞, objectType=article, longId=159378, objectId=d85f1593e830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d85f1593e830, replyNumber=0, likeNumber=52, createdTime=2019-02-07, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d85f1593e830, moduleTitle=INT J LAB HEMATOL：利用CD81/CD58的表达率很容易从B细胞祖细胞急性淋巴细胞白血病患者淋巴母细胞中识别造血细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d85f1593e830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997918, encodeId=1761199e91808, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2018 北美专家共识建议：成人急性淋巴细胞白血病可测量残留病评估和管理, objectType=article, longId=153477, objectId=0dd91534e715, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dd91534e715, replyNumber=0, likeNumber=30, createdTime=2019-01-27, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dd91534e715, moduleTitle=2018 北美专家共识建议：成人急性淋巴细胞白血病可测量残留病评估和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0dd91534e715)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997910, encodeId=4d92199e910bb, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：RPS15突变型慢性淋巴细胞白血病整体蛋白质合成模式和翻译保真度均发生改变, objectType=article, longId=148290, objectId=6e45148290b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e45148290b2, replyNumber=0, likeNumber=132, createdTime=2019-06-28, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e45148290b2, moduleTitle=Blood：RPS15突变型慢性淋巴细胞白血病整体蛋白质合成模式和翻译保真度均发生改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e45148290b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997914, encodeId=4943199e914c9, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V2）, objectType=article, longId=150979, objectId=fd051509e9f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd051509e9f0, replyNumber=0, likeNumber=23, createdTime=2018-12-09, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd051509e9f0, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd051509e9f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997906, encodeId=f6bc199e906cf, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=IJLH：使用定制的靶向富集系统组同时检测费城染色体阳性急性淋巴细胞白血病中ABL1突变和IKZF1缺失, objectType=article, longId=145618, objectId=188e14561831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=188e14561831, replyNumber=0, likeNumber=51, createdTime=2018-12-22, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=188e14561831, moduleTitle=IJLH：使用定制的靶向富集系统组同时检测费城染色体阳性急性淋巴细胞白血病中ABL1突变和IKZF1缺失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=188e14561831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997904, encodeId=1d38199e904b9, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=2018 BSH指南：慢性淋巴细胞白血病的治疗, objectType=article, longId=144801, objectId=bbb014480130, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbb014480130, replyNumber=0, likeNumber=18, createdTime=2018-09-28, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbb014480130, moduleTitle=2018 BSH指南：慢性淋巴细胞白血病的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbb014480130)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997933, encodeId=3a57199e93338, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Imbruvica和Gazyvo联用获FDA批准用于治疗慢性淋巴细胞白血病, objectType=article, longId=159146, objectId=e3eb15914659, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3eb15914659, replyNumber=0, likeNumber=91, createdTime=2019-10-11, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3eb15914659, moduleTitle=Imbruvica和Gazyvo联用获FDA批准用于治疗慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3eb15914659)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997939, encodeId=343e199e93930, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Leukemia：发现克服儿童急性淋巴细胞白血病耐药复发潜在治疗靶点, objectType=article, longId=164428, objectId=b0e71644283f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0e71644283f, replyNumber=0, likeNumber=62, createdTime=2019-10-06, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0e71644283f, moduleTitle=Leukemia：发现克服儿童急性淋巴细胞白血病耐药复发潜在治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0e71644283f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997919, encodeId=18f2199e919bf, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：如何治疗费城染色体阳性的急性淋巴细胞白血病？, objectType=article, longId=153814, objectId=5eb6153814dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5eb6153814dd, replyNumber=0, likeNumber=58, createdTime=2019-02-07, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5eb6153814dd, moduleTitle=Blood：如何治疗费城染色体阳性的急性淋巴细胞白血病？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5eb6153814dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997940, encodeId=038e199e9409f, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=新研究显示BCL2抑制剂联合CD20单抗治疗慢性淋巴细胞白血病，缓解率达95%, objectType=article, longId=164498, objectId=282016449820, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=282016449820, replyNumber=0, likeNumber=65, createdTime=2019-11-17, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=282016449820, moduleTitle=新研究显示BCL2抑制剂联合CD20单抗治疗慢性淋巴细胞白血病，缓解率达95%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=282016449820)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞白血病

2020-05-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：Venetoclax联合奥比妥单抗治疗慢性淋巴细胞白血病的疗效和安全性

2020-01-09

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：依鲁替尼联合利妥昔单抗与依鲁替尼单药治疗慢性淋巴细胞白血病的效果对比

2019-04-16

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

CAR-T治疗复发难治急性B淋巴细胞白血病缓解率高

2019-06-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NCCN临床实践指南：急性淋巴细胞白血病（2019.V1）

2020-01-14

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

【2018 ASH】徐卫教授速递：伊布替尼在慢性淋巴细胞白血病领域治疗取得哪些突破？

2019-11-04

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

儿童急性淋巴细胞白血病诊疗规范（2018版）

2019-07-04

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2019 EHA：AZ的BTK抑制剂Calquence显着延长慢性淋巴细胞白血病患者的无进展生存期

2019-10-01

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2018年ASH年会：KTE-X19治疗成人复发难治急性淋巴细胞白血病患者的全新结果

2019-04-04

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

慢性淋巴细胞白血病：Calquence达到III期临床试验的主要终点

2020-01-23

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

AbbVie的BCL-2抑制剂VENCLEXTA获得加拿大批准与利妥昔单抗联合治疗慢性淋巴细胞白血病患者

2019-04-24

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

INT J LAB HEMATOL：利用CD81/CD58的表达率很容易从B细胞祖细胞急性淋巴细胞白血病患者淋巴母细胞中识别造血细胞

2019-02-07

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2018 北美专家共识建议：成人急性淋巴细胞白血病可测量残留病评估和管理

2019-01-27

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：RPS15突变型慢性淋巴细胞白血病整体蛋白质合成模式和翻译保真度均发生改变

2019-06-28

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V2）

2018-12-09

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

IJLH：使用定制的靶向富集系统组同时检测费城染色体阳性急性淋巴细胞白血病中ABL1突变和IKZF1缺失

2018-12-22

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

2018 BSH指南：慢性淋巴细胞白血病的治疗

2018-09-28

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Imbruvica和Gazyvo联用获FDA批准用于治疗慢性淋巴细胞白血病

2019-10-11

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Leukemia：发现克服儿童急性淋巴细胞白血病耐药复发潜在治疗靶点

2019-10-06

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：如何治疗费城染色体阳性的急性淋巴细胞白血病？

2019-02-07

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

新研究显示BCL2抑制剂联合CD20单抗治疗慢性淋巴细胞白血病，缓解率达95%

2019-11-17

科室
- - 订阅+
  - 更多科室
工具
服务